Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT prolongation for cancer therapy
US9138411B2 · kind B2 · utility
12Cited by
15References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 31, 2013 |
| Grant date | Sep 22, 2015 |
| Priority date | — |
| Expiry date | Aug 31, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes compositions and methods of making a nanoparticle composition comprising a polymeric core comprising one or more polymers and one or more active agents, and at least one layer of one or more lipids on the surface of the polymeric core; more specifically, the invention relates to the use of curcumin within such a lipid-polymer nanoparticle formulation for minimizing QT prolongation associated with curcumin in treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.